Deferiprone

What is Deferiprone?

Deferiprone (tradenames include Ferriprox) is a drug that chelates iron and is used to treat thalassaemia major. On October 14, 2011, it was approved for use in the US under the FDA’s accelerated approval program.

Deferiprone was at the center of a protracted struggle between Nancy Olivieri, a Canadian haematologist and researcher, and the Hospital for Sick Children and pharmaceutical giant Apotex, that started in 1996 and delayed approval of the drug in North America. Dr. Olivieri's data suggested deferiprone leads to progressive hepatic fibrosis.

Questions and answers on "Deferiprone"

my husband has MDS, and has had it since 2006, last month he had another bone marrow biopsy and the MDS has not progressed, it is the same as in...

doctor1 MD

mds is mylodyplastic syndrome in this case some chromosomal mutation occurs in the blast cell of bone marrow resulting anemia pancytopenia .so...

Read Full Thread   Ask a Doctor Now

Recent questions on  Deferiprone

doctor1 MD

my husband has MDS, and has had it since 2006, last month he had another bone marrow biopsy and the MDS has not progressed, it is the same as in...

Ask Question
Doctor Image
MD

Hi, I am Dr. Andrew Rynne (Family Physician). I will be guiding you through the process. Please write your question below.

Related Disease & Conditions